Trial Profile
Glimepiride/sustained-release metformin vs glimepiride/immediate-release metformin (single dose or q12h) in male South Korean volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Feb 2012
Price :
$35
*
At a glance
- Drugs Glimepiride/metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 03 Feb 2012 New trial record
- 01 Feb 2012 Results published in the International Journal of Clinical Pharmacology and Therapeutics.